APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Bifidobacterium Probiotics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bifidobacterium Probiotics Market Outlook and Growth Opportunities 2026

6 July 2026195 pages

Choose your research edition.

Industry ResearchBifidobacterium Probiotics Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Bifidobacterium Probiotics Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Bifidobacterium Probiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bifidobacterium Probiotics Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Bifidobacterium Probiotics Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Bifidobacterium Probiotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bifidobacterium Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bifidobacterium Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bifidobacterium Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bifidobacterium Probiotics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bifidobacterium Probiotics market include DuPont(Danisco), Chr. Hansen, Lallemand, China-Biotics, Nestle, Danone, Probi, BioGaia and Yakult, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bifidobacterium Probiotics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bifidobacterium Probiotics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bifidobacterium Probiotics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bifidobacterium Probiotics market size, projected growth trends, production technologies, key applications, and end-use industries.

Bifidobacterium Probiotics Segment by Company

DuPont(Danisco)

Chr. Hansen

Lallemand

China-Biotics

Nestle

Danone

Probi

BioGaia

Yakult

Novozymes

Bifidobacterium Probiotics Segment by Type

Liquid

Powder

Bifidobacterium Probiotics Segment by Application

Food & Beverage

Drugs

Dietary Supplements

Others

Bifidobacterium Probiotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bifidobacterium Probiotics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bifidobacterium Probiotics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bifidobacterium Probiotics significant trends, drivers, influence factors in global and regions.

6. To analyze Bifidobacterium Probiotics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifidobacterium Probiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bifidobacterium Probiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifidobacterium Probiotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bifidobacterium Probiotics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bifidobacterium Probiotics industry.

Chapter 3: Detailed analysis of Bifidobacterium Probiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bifidobacterium Probiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bifidobacterium Probiotics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bifidobacterium Probiotics Industry Trends Table 2. Bifidobacterium Probiotics Industry Drivers Table 3. Bifidobacterium Probiotics Industry Opportunities and Challenges Table 4. Bifidobacterium Probiotics Industry Restraints Table 5. Global Bifidobacterium Probiotics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bifidobacterium Probiotics Revenue Share by Company (2021-2026) Table 7. Global Bifidobacterium Probiotics Sales Volume by Company (t) & (2021-2026) Table 8. Global Bifidobacterium Probiotics Sales Volume Share by Company (2021-2026) Table 9. Global Bifidobacterium Probiotics Average Price (USD/t) of Company (2021-2026) Table 10. Global Bifidobacterium Probiotics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bifidobacterium Probiotics Key Company Manufacturing Base & Headquarters Table 12. Global Bifidobacterium Probiotics Company, Product Type & Application Table 13. Global Bifidobacterium Probiotics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bifidobacterium Probiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Liquid Table 18. Significant Companies of Powder Table 19. Global Bifidobacterium Probiotics Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 20. Global Bifidobacterium Probiotics Sales Volume by Type (2021-2026) & (t) Table 21. Global Bifidobacterium Probiotics Sales Volume by Type (2027-2032) & (t) Table 22. Global Bifidobacterium Probiotics Sales Volume Share by Type (2021-2026) Table 23. Global Bifidobacterium Probiotics Sales Volume Share by Type (2027-2032) Table 24. Global Bifidobacterium Probiotics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Bifidobacterium Probiotics Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Bifidobacterium Probiotics Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Bifidobacterium Probiotics Sales Value Share by Type (2021-2026) Table 28. Global Bifidobacterium Probiotics Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Food & Beverage Table 30. Significant Companies of Drugs Table 31. Significant Companies of Dietary Supplements Table 32. Significant Companies of Others Table 33. Global Bifidobacterium Probiotics Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 34. Global Bifidobacterium Probiotics Sales Volume by Application (2021-2026) & (t) Table 35. Global Bifidobacterium Probiotics Sales Volume by Application (2027-2032) & (t) Table 36. Global Bifidobacterium Probiotics Sales Volume Share by Application (2021-2026) Table 37. Global Bifidobacterium Probiotics Sales Volume Share by Application (2027-2032) Table 38. Global Bifidobacterium Probiotics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Bifidobacterium Probiotics Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Bifidobacterium Probiotics Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Bifidobacterium Probiotics Sales Value Share by Application (2021-2026) Table 42. Global Bifidobacterium Probiotics Sales Value Share by Application (2027-2032) Table 43. Global Bifidobacterium Probiotics Sales by Region: 2021 VS 2025 VS 2032 (t) Table 44. Global Bifidobacterium Probiotics Sales by Region (2021-2026) & (t) Table 45. Global Bifidobacterium Probiotics Sales Market Share by Region (2021-2026) Table 46. Global Bifidobacterium Probiotics Sales by Region (2027-2032) & (t) Table 47. Global Bifidobacterium Probiotics Sales Market Share by Region (2027-2032) Table 48. Global Bifidobacterium Probiotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Bifidobacterium Probiotics Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Bifidobacterium Probiotics Sales Value Share by Region (2021-2026) Table 51. Global Bifidobacterium Probiotics Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Bifidobacterium Probiotics Sales Value Share by Region (2027-2032) Table 53. Global Bifidobacterium Probiotics Market Average Price (USD/t) by Region (2021-2026) Table 54. Global Bifidobacterium Probiotics Market Average Price (USD/t) by Region (2027-2032) Table 55. Global Bifidobacterium Probiotics Sales by Country: 2021 VS 2025 VS 2032 (t) Table 56. Global Bifidobacterium Probiotics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Bifidobacterium Probiotics Sales by Country (2021-2026) & (t) Table 58. Global Bifidobacterium Probiotics Sales Market Share by Country (2021-2026) Table 59. Global Bifidobacterium Probiotics Sales by Country (2027-2032) & (t) Table 60. Global Bifidobacterium Probiotics Sales Market Share by Country (2027-2032) Table 61. Global Bifidobacterium Probiotics Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Bifidobacterium Probiotics Sales Value Market Share by Country (2021-2026) Table 63. Global Bifidobacterium Probiotics Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Bifidobacterium Probiotics Sales Value Market Share by Country (2027-2032) Table 65. DuPont(Danisco) Company Information Table 66. DuPont(Danisco) Business Overview Table 67. DuPont(Danisco) Bifidobacterium Probiotics Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 68. DuPont(Danisco) Bifidobacterium Probiotics Product Portfolio Table 69. DuPont(Danisco) Recent Development Table 70. Chr. Hansen Company Information Table 71. Chr. Hansen Business Overview Table 72. Chr. Hansen Bifidobacterium Probiotics Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 73. Chr. Hansen Bifidobacterium Probiotics Product Portfolio Table 74. Chr. Hansen Recent Development Table 75. Lallemand Company Information Table 76. Lallemand Business Overview Table 77. Lallemand Bifidobacterium Probiotics Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 78. Lallemand Bifidobacterium Probiotics Product Portfolio Table 79. Lallemand Recent Development Table 80. China-Biotics Company Information Table 81. China-Biotics Business Overview Table 82. China-Biotics Bifidobacterium Probiotics Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 83. China-Biotics Bifidobacterium Probiotics Product Portfolio Table 84. China-Biotics Recent Development Table 85. Nestle Company Information Table 86. Nestle Business Overview Table 87. Nestle Bifidobacterium Probiotics Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 88. Nestle Bifidobacterium Probiotics Product Portfolio Table 89. Nestle Recent Development Table 90. Danone Company Information Table 91. Danone Business Overview Table 92. Danone Bifidobacterium Probiotics Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 93. Danone Bifidobacterium Probiotics Product Portfolio Table 94. Danone Recent Development Table 95. Probi Company Information Table 96. Probi Business Overview Table 97. Probi Bifidobacterium Probiotics Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 98. Probi Bifidobacterium Probiotics Product Portfolio Table 99. Probi Recent Development Table 100. BioGaia Company Information Table 101. BioGaia Business Overview Table 102. BioGaia Bifidobacterium Probiotics Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 103. BioGaia Bifidobacterium Probiotics Product Portfolio Table 104. BioGaia Recent Development Table 105. Yakult Company Information Table 106. Yakult Business Overview Table 107. Yakult Bifidobacterium Probiotics Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 108. Yakult Bifidobacterium Probiotics Product Portfolio Table 109. Yakult Recent Development Table 110. Novozymes Company Information Table 111. Novozymes Business Overview Table 112. Novozymes Bifidobacterium Probiotics Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 113. Novozymes Bifidobacterium Probiotics Product Portfolio Table 114. Novozymes Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Bifidobacterium Probiotics Distributors List Table 118. Bifidobacterium Probiotics Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Bifidobacterium Probiotics Product Image Figure 2. Global Bifidobacterium Probiotics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bifidobacterium Probiotics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bifidobacterium Probiotics Sales (2021-2032) & (t) Figure 5. Global Bifidobacterium Probiotics Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Bifidobacterium Probiotics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Liquid Image Figure 10. Powder Image Figure 11. Global Bifidobacterium Probiotics Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 12. Global Bifidobacterium Probiotics Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Bifidobacterium Probiotics Sales Volume Share by Type (2021-2032) Figure 14. Global Bifidobacterium Probiotics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Bifidobacterium Probiotics Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Bifidobacterium Probiotics Sales Value Share by Type (2021-2032) Figure 17. Food & Beverage Image Figure 18. Drugs Image Figure 19. Dietary Supplements Image Figure 20. Others Image Figure 21. Global Bifidobacterium Probiotics Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 22. Global Bifidobacterium Probiotics Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Bifidobacterium Probiotics Sales Volume Share by Application (2021-2032) Figure 24. Global Bifidobacterium Probiotics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Bifidobacterium Probiotics Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Bifidobacterium Probiotics Sales Value Share by Application (2021-2032) Figure 27. Global Bifidobacterium Probiotics Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 28. Global Bifidobacterium Probiotics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Bifidobacterium Probiotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Bifidobacterium Probiotics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Bifidobacterium Probiotics Sales Value (2021-2032) & (US$ Million) Figure 32. North America Bifidobacterium Probiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Bifidobacterium Probiotics Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Bifidobacterium Probiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Bifidobacterium Probiotics Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Bifidobacterium Probiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Bifidobacterium Probiotics Sales Value (2021-2032) & (US$ Million) Figure 38. South America Bifidobacterium Probiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Bifidobacterium Probiotics Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Bifidobacterium Probiotics Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Bifidobacterium Probiotics Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Bifidobacterium Probiotics Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid
  • Powder
Applications
  • Food & Beverage
  • Drugs
  • Dietary Supplements
  • Others
Companies covered
  • DuPont(Danisco)
  • Chr. Hansen
  • Lallemand
  • China-Biotics
  • Nestle
  • Danone
  • Probi
  • BioGaia
  • Yakult
  • Novozymes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bifidobacterium Probiotics Sales Value (2021-2032)
  4. 1.2.2 Global Bifidobacterium Probiotics Sales Volume (2021-2032)
  5. 1.2.3 Global Bifidobacterium Probiotics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bifidobacterium Probiotics Market Dynamics
  1. 2.1 Bifidobacterium Probiotics Industry Trends
  2. 2.2 Bifidobacterium Probiotics Industry Drivers
  3. 2.3 Bifidobacterium Probiotics Industry Opportunities and Challenges
  4. 2.4 Bifidobacterium Probiotics Industry Restraints
3 Bifidobacterium Probiotics Market by Company
  1. 3.1 Global Bifidobacterium Probiotics Company Revenue Ranking in 2025
  2. 3.2 Global Bifidobacterium Probiotics Revenue by Company (2021-2026)
  3. 3.3 Global Bifidobacterium Probiotics Sales Volume by Company (2021-2026)
  4. 3.4 Global Bifidobacterium Probiotics Average Price by Company (2021-2026)
  5. 3.5 Global Bifidobacterium Probiotics Company Ranking (2024-2026)
  6. 3.6 Global Bifidobacterium Probiotics Company Manufacturing Base and Headquarters
  7. 3.7 Global Bifidobacterium Probiotics Company Product Type and Application
  8. 3.8 Global Bifidobacterium Probiotics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bifidobacterium Probiotics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bifidobacterium Probiotics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bifidobacterium Probiotics Market by Type
  1. 4.1 Bifidobacterium Probiotics Type Introduction
  2. 4.1.1 Liquid
  3. 4.1.2 Powder
  4. 4.2 Global Bifidobacterium Probiotics Sales Volume by Type
  5. 4.2.1 Global Bifidobacterium Probiotics Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bifidobacterium Probiotics Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Bifidobacterium Probiotics Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Bifidobacterium Probiotics Sales Value by Type
  9. 4.3.1 Global Bifidobacterium Probiotics Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bifidobacterium Probiotics Sales Value by Type (2021-2032)
  11. 4.3.3 Global Bifidobacterium Probiotics Sales Value Share by Type (2021-2032)
5 Bifidobacterium Probiotics Market by Application
  1. 5.1 Bifidobacterium Probiotics Application Introduction
  2. 5.1.1 Food & Beverage
  3. 5.1.2 Drugs
  4. 5.1.3 Dietary Supplements
  5. 5.1.4 Others
  6. 5.2 Global Bifidobacterium Probiotics Sales Volume by Application
  7. 5.2.1 Global Bifidobacterium Probiotics Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Bifidobacterium Probiotics Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Bifidobacterium Probiotics Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Bifidobacterium Probiotics Sales Value by Application
  11. 5.3.1 Global Bifidobacterium Probiotics Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Bifidobacterium Probiotics Sales Value by Application (2021-2032)
  13. 5.3.3 Global Bifidobacterium Probiotics Sales Value Share by Application (2021-2032)
6 Bifidobacterium Probiotics Regional Sales and Value Analysis
  1. 6.1 Global Bifidobacterium Probiotics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bifidobacterium Probiotics Sales by Region (2021-2032)
  3. 6.2.1 Global Bifidobacterium Probiotics Sales by Region: 2021-2026
  4. 6.2.2 Global Bifidobacterium Probiotics Sales by Region (2027-2032)
  5. 6.3 Global Bifidobacterium Probiotics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bifidobacterium Probiotics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bifidobacterium Probiotics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bifidobacterium Probiotics Sales Value by Region (2027-2032)
  9. 6.5 Global Bifidobacterium Probiotics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bifidobacterium Probiotics Sales Value (2021-2032)
  12. 6.6.2 North America Bifidobacterium Probiotics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bifidobacterium Probiotics Sales Value (2021-2032)
  15. 6.7.2 Europe Bifidobacterium Probiotics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bifidobacterium Probiotics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bifidobacterium Probiotics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bifidobacterium Probiotics Sales Value (2021-2032)
  21. 6.9.2 South America Bifidobacterium Probiotics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bifidobacterium Probiotics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bifidobacterium Probiotics Sales Value Share by Country, 2025 VS 2032
7 Bifidobacterium Probiotics Country-level Sales and Value Analysis
  1. 7.1 Global Bifidobacterium Probiotics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bifidobacterium Probiotics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bifidobacterium Probiotics Sales by Country (2021-2032)
  4. 7.3.1 Global Bifidobacterium Probiotics Sales by Country (2021-2026)
  5. 7.3.2 Global Bifidobacterium Probiotics Sales by Country (2027-2032)
  6. 7.4 Global Bifidobacterium Probiotics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bifidobacterium Probiotics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bifidobacterium Probiotics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bifidobacterium Probiotics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bifidobacterium Probiotics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bifidobacterium Probiotics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 DuPont(Danisco)
  2. 8.1.1 DuPont(Danisco) Company Information
  3. 8.1.2 DuPont(Danisco) Business Overview
  4. 8.1.3 DuPont(Danisco) Bifidobacterium Probiotics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 DuPont(Danisco) Bifidobacterium Probiotics Product Portfolio
  6. 8.1.5 DuPont(Danisco) Recent Developments
  7. 8.2 Chr. Hansen
  8. 8.2.1 Chr. Hansen Company Information
  9. 8.2.2 Chr. Hansen Business Overview
  10. 8.2.3 Chr. Hansen Bifidobacterium Probiotics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Chr. Hansen Bifidobacterium Probiotics Product Portfolio
  12. 8.2.5 Chr. Hansen Recent Developments
  13. 8.3 Lallemand
  14. 8.3.1 Lallemand Company Information
  15. 8.3.2 Lallemand Business Overview
  16. 8.3.3 Lallemand Bifidobacterium Probiotics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lallemand Bifidobacterium Probiotics Product Portfolio
  18. 8.3.5 Lallemand Recent Developments
  19. 8.4 China-Biotics
  20. 8.4.1 China-Biotics Company Information
  21. 8.4.2 China-Biotics Business Overview
  22. 8.4.3 China-Biotics Bifidobacterium Probiotics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 China-Biotics Bifidobacterium Probiotics Product Portfolio
  24. 8.4.5 China-Biotics Recent Developments
  25. 8.5 Nestle
  26. 8.5.1 Nestle Company Information
  27. 8.5.2 Nestle Business Overview
  28. 8.5.3 Nestle Bifidobacterium Probiotics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Nestle Bifidobacterium Probiotics Product Portfolio
  30. 8.5.5 Nestle Recent Developments
  31. 8.6 Danone
  32. 8.6.1 Danone Company Information
  33. 8.6.2 Danone Business Overview
  34. 8.6.3 Danone Bifidobacterium Probiotics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Danone Bifidobacterium Probiotics Product Portfolio
  36. 8.6.5 Danone Recent Developments
  37. 8.7 Probi
  38. 8.7.1 Probi Company Information
  39. 8.7.2 Probi Business Overview
  40. 8.7.3 Probi Bifidobacterium Probiotics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Probi Bifidobacterium Probiotics Product Portfolio
  42. 8.7.5 Probi Recent Developments
  43. 8.8 BioGaia
  44. 8.8.1 BioGaia Company Information
  45. 8.8.2 BioGaia Business Overview
  46. 8.8.3 BioGaia Bifidobacterium Probiotics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 BioGaia Bifidobacterium Probiotics Product Portfolio
  48. 8.8.5 BioGaia Recent Developments
  49. 8.9 Yakult
  50. 8.9.1 Yakult Company Information
  51. 8.9.2 Yakult Business Overview
  52. 8.9.3 Yakult Bifidobacterium Probiotics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Yakult Bifidobacterium Probiotics Product Portfolio
  54. 8.9.5 Yakult Recent Developments
  55. 8.10 Novozymes
  56. 8.10.1 Novozymes Company Information
  57. 8.10.2 Novozymes Business Overview
  58. 8.10.3 Novozymes Bifidobacterium Probiotics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Novozymes Bifidobacterium Probiotics Product Portfolio
  60. 8.10.5 Novozymes Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bifidobacterium Probiotics Value Chain Analysis
  2. 9.1.1 Bifidobacterium Probiotics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bifidobacterium Probiotics Sales Mode & Process
  6. 9.2 Bifidobacterium Probiotics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bifidobacterium Probiotics Distributors
  9. 9.2.3 Bifidobacterium Probiotics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst